ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 155 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $452,000 | -85.8% | 12,150 | -80.5% | 0.01% | -86.4% |
| Q2 2020 | $3,189,000 | +62.7% | 62,150 | 0.0% | 0.04% | +41.9% |
| Q1 2020 | $1,960,000 | -48.6% | 62,150 | 0.0% | 0.03% | -18.4% |
| Q4 2019 | $3,813,000 | +64.7% | 62,150 | -1.6% | 0.04% | +52.0% |
| Q3 2019 | $2,315,000 | -21.2% | 63,135 | 0.0% | 0.02% | -21.9% |
| Q2 2019 | $2,938,000 | +46.3% | 63,135 | +26.3% | 0.03% | +45.5% |
| Q1 2019 | $2,008,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |